Pharming Group N.V.

NASDAQ: PHAR · Real-Time Price · USD
12.74
1.09 (9.36%)
At close: Aug 18, 2025, 2:45 PM

Pharming Ratios and Metrics

Financials in EUR. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-62.97 -71.2 71.30 43.08
PEG Ratio
-10.14 0.38 -4.46 -0.76
PS Ratio
2.26 3.06 4.74 3.63
PB Ratio
3.03 3.43 4.76 3.58
P/FCF Ratio
-258.67 -40.02 46.60 34.16
P/OCF Ratio
-373.37 -43.4 42.58 19.07
OCF/S Ratio
-0.01 -0.07 0.11 0.19
Debt / Equity Ratio
0.49 0.78 0.81 0.84
Quick Ratio
3.02 3.40 3.94 4.75
Current Ratio
3.77 4.06 4.65 5.33
Asset Turnover
0.74 0.53 0.48 0.48
Interest Coverage
-0.99 -0.82 3.34 4.51
Return on Equity
-0.05 -0.05 0.07 0.08
Return on Assets
-0.03 -0.02 0.03 0.04
Return on Invested Capital
-0.03 -0.01 0.04 0.05
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.88 0.90 0.91 0.89
Net Profit Margin
-0.04 -0.04 0.07 0.08
Pretax Profit Margin
-0.03 -0.05 0.07 0.12
Operating Profit Margin
-0.03 -0.02 0.09 0.15
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
0.05 0.04 0.16 0.26